Skip to main content

Table 1 Laboratory findings upon admission (on day 44)

From: Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report

Blood test Urine test
 White blood cell 3800/μL C-reactive protein 0.09 mg/dL  Gravity 1.023
 Neutrophil 57.6% IgG 590 mg/dL  pH 6.0
 Lymphocyte 29.3% IgA 125 mg/dL  Protein 4+
 Hemoglobin 11.3 g/dL IgM 72 mg/dL  Occult blood 3+
 Hematocrit 33.7% Complement 3 109 mg/dL  White blood cell 0 /HPF
 Platelet 57,000/μL Complement 4 18.8 mg/dL  Red blood cell 10–19 /HPF
 Total protein 5.7 g/dL CH50 47 IU/mL  Dysmorphic erythrocyte +
 Albumin 3.0 g/dL Hepatitis B s antigen  Protein 941 mg/dL
 Blood urea nitrogen 19 mg/dL Hepatitis C virus antibody  Creatinine 184 mg/dL
 Creatinine 0.65 mg/dL     
  1. HPF high power field